Zydus Cadila
Everolimus (0.25mg)
Everomus 0.25mg Tablet is used for the prevention of organ rejection in transplant patients and in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Tablet
Everomus 0.25mg Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body's immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Everomus 0.25mg Tablet may be taken with or without food but it is better to take it at a fixed time.
Everomus 0.25mg Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.
Everomus 0.25mg Tablet is given for the treatment of certain cancers and to prevent organ transplant rejection. It may affect male or female fertility; consult your doctor if you are planning to have a child. Inform your doctor straight away if you think you are getting a sore throat or if you have a high temperature. While you are taking Everomus 0.25mg Tablet do not take any vaccinations without talking to your doctor first. If you are having an operation or dental treatment, always tell the person carrying out the treatment that you are taking Everomus 0.25mg Tablet. Do not drink grapefruit juice while you are taking this medicine.
Regular blood tests are necessary while taking Everomus 0.25mg Tablet. These tests will assess red blood cell, white blood cell, and platelet counts. Additionally, blood tests will evaluate kidney function, liver function, blood glucose levels, and cholesterol levels.
Grapefruit or grapefruit juice should be avoided concurrently with Everomus 0.25mg Tablet as this may increase the drug's concentration in your blood to harmful levels. Live vaccinations must also be avoided, along with any potential contact with individuals who have received live vaccinations.
Serious side effects of Everomus 0.25mg Tablet can occur, including severe allergic reactions, angioedema, and kidney failure. These could be life-threatening. Additionally, infections or lung complications like breathing problems are possible.
Everomus 0.25mg Tablet is an anticancer medication belonging to the kinase inhibitor class. It works by reducing blood supply to tumors, slowing down cancer cell growth and spread.
Everomus 0.25mg Tablet is typically taken once or twice daily. It should be taken either with food or without food, always swallowed whole with water, and not crushed or chewed.
The duration of treatment with Everomus 0.25mg Tablet is variable. It continues until clinical benefit is observed or unacceptable toxicity or side effects occur.
The effect of Everomus 0.25mg Tablet on tumor size can be assessed using regular brain scans, as advised by your doctor and incorporated into your treatment plan.
Yes, Everomus 0.25mg Tablet is cytotoxic against human cancer cells of the breast, stomach, prostate, and kidneys (renal cell carcinoma).